Sodium status, corticosteroid metabolism and blood pressure in normal human subjects and in a patient with abnormal salt appetite

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 5, 1996, Pages 375-378

  Ingram, Mary C ^a   Wallace, A Michael ^b   Collier, Andrew ^a   Fraser, Robert ^a   Connell, John M C ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

11 hydroxysteroid dehydrogenase; Blood pressure; Essential hypertension; Sodium appetite

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; ANGIOTENSIN; POTASSIUM; RENIN; SODIUM;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ENZYME DEFICIENCY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; SALT INTAKE;

EID: 0029888213     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb02744.x     Document Type: Article

References (22)

1. Funder JW, Pearce PT, Smith R, Smith AT. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor mediated. Science 1987; 242: 583-5.
2. Stewart PM, Corrie JET, Shackleton CHL, Edwards CRW. Syndrome of apparent mineralocorticoid excess: A defect in the cortisol-cortisone shuttle. J. Clin. Invest. 1988; 82: 340-9.
3. Ulick S, Ramirez LC, New MI. An abnormality of steroid reductive metabolism in a hypertensive syndrome. J. Clin. Endocrinol. Metab. 1977; 44: 799-802.
4. Ulick S, Tedde R, Wang JZ. Defective ring A reduction of cortisol as a major metabolic error in the syndrome of apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 1992; 74: 593-9.
5. Stewart PM, Atherden SM, Shearing CH, Edwards CRW. Mineralocorticoid activity of carbenoxolone: Contrasting effects of carbenoxolone and liquorice on 11β-hydroxysteroid dehydrogenase activity in man. Clin. Sci. 1990; 78: 49-54.
6. Fraser R, Guest S, Young J. Comparison of radioimmunoassay and physiochemical methods as means of estimating plasma aldosterone and 11-deoxycorticosterone concentrations. In: Cameron EHD, Hillier SG, Griffiths K (eds). Steroid Immunoassay. Cariff, Alpha Omega Publishing. 1975; 283-92.
7. Morton JJ, Webb DJ. Measurement of angiotensin II. Clin. Sci. 1986; 68: 483-4.
8. Shackleton CHL. Profiling steroid hormones and urinary steroids J. Chromatogr. 1986; 379: 91-156.
9. 24Na. Metabolism 1973; 22: 133-7.
10. Soltis EE, Bohr DF. Central action of sodium chloride on whole body pressor responsiveness in the DOCA-treated rat. J. Hypertens. 1989; 7: 383-6.
11. Connell JMC, Whitworth JA, Davies DL, Richards AM, Fraser R. Haemodynamic, hormonal and renal effects of adrenocorticotrophic hormone in sodium-restricted man. J. Hypertens. 1988; 6: 17-23.
12. Kirkendall WM, Connor WE, Abboud F, Rastogi SP, Anderson TA, Fry M. The effect of dietary sodium chloride on blood pressure, body fluids, electrolytes, renal function and serum lipids. J. Lab. Ciln. Med. 1976; 87: 418-34.
13. Luft FC, Zemel MB, Sowers JA, Fineberg NS, Weinberger MH. Sodium bicarbonate and sodium chloride: Effects on blood pressure and electrolyte homeostasis in normal and hypertensive men. J. Hypertens. 1990; 8: 663-70.
14. Houston MC. Sodium and hypertension. A review. Arch. Int. Med. 1986; 146: 179-85.
15. Davies DL, Beevers DG, Brown JJ et al. Aldosterone and its stimuli in normal and hypertensive man: Are essential hypertension and primary hyperaldosteronism without tumour the same condition? J. Endocrin. 1979; 81: 79P-91P.
16. Ferris JB. Primary hyperaldosteronism: Conn's syndrome and similar disorders. In: Robertson JIS (ed). Handbook of Hypertension, vol. 15 (Clinical Hypertension), Elsevier: Amsterdam, pp 357-89.
17. Fraser R. Inborn errors of corticosteroid biosynthesis and metabolism; their effects on electrolyte metabolism. In: Robertson JIS (ed.). Handbook of Hypertension, vol. 15. Elsevier, Amsterdam. 1992; 420-60.
18. Isles CG, Macdougall IC, Lever AF, Fraser R. Hypermineralocorticoidism due to adrenal carcinoma: Plasma corticosteroids and their response to ACTH and angiotensin II. Clin. Endocrinol. 1987; 26: 239-51.
19. Kisch ES, Dluhy RG, Williams GH. Enhanced aldosterone response to angiotensin II in human hypertension. Circ. Res. 1976; 38: 502-5.
20. de Simone G, Tommaselli AP, Rossi R et al. Partial deficiency of adrenal 11β-hydroxylase. A possible cause of primary hypertension. Hypertension 1985; 7: 204-10.
21. Walker BR, Stewart PM, Shackleton CHL, Padfield PL, Edwards CRW. Deficient inactivation of Cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension. Clin. Endocrinol. 1993; 39: 221-7.
22. Soro A, Ingram MC, Tonolo G, Glorioso N, Fraser R. Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in subjects with untreated essential hypertension. Hypertension 1995; 25: 67-70.